Facebook-f Twitter Instagram
Register your interest
Main Menu

Welcome

We are delighted to invite you to the 2025 Asian Federation for Pharmaceutical Sciences (AFPS) Conference from 3 to 5 December 2025 in Sydney. 

This conference will unite pharmaceutical scientists, researchers, and industry leaders from across Asia and beyond for three days of innovation, collaboration, and knowledge exchange.

‘One Health – Unifying Science, Innovation, and Humanity for a Sustainable Future’

Our conference theme reflects the critical intersection of health, environmental sustainability, and technological advancement. Through the central message of ‘Unifying Medicine, Nature, and Technology,’ we aim to foster meaningful dialogue and inspire solutions to today’s most pressing health challenges.

Why attend AFPS 2025?

  • Access cutting-edge pharmaceutical research and insights from industry leaders, regulatory bodies, and academia through keynote talks, panel discussions, and poster sessions
  • Experience live demonstrations of innovative technologies including AI-driven drug discovery, precision medicine tools, and digital therapeutics
  • Enhance your expertise through hands-on workshops and specialised training in laboratory techniques, regulatory compliance, and data analytics
  • Build valuable connections with international researchers, industry partners, and collaborators through mentoring sessions and themed networking events
  • Contribute to discussions on critical topics like bio convergence, sustainable manufacturing, and the future of pharmacy education
  • Participate in innovation challenges and collaborative problem-solving sessions focused on real-world pharmaceutical industry challenges
Signup for email updates

We look forward to welcoming you to Sydney for what promises to be an inspiring and rewarding event.

Prof Wojciech Chrzanowski
Co-chair
Prof Lee Yong Lim
Co-chair
Dr Philip Kwok
Co-chair
Prof Andrew McLachlan
Chief Patron

Plenary speakers

Prof Clara Chow

Prof Clara Chow

Professor Clara Chow is Academic Director of the Westmead Applied Research Centre (WARC), Faculty of Medicine and Health, University of Sydney. She is a cardiologist and Clinical Lead of Community Based Cardiac Services at Westmead hospital and is also a member of the Western Sydney Local Health District (WSLHD) Governing Board, Sydney, Australia. Professor Chow is Director of the Australian Stroke and Heart Accelerator (ASHRA). Her recent award highlights include being a finalist for the NSW Premier’s Woman of the Year - Woman of Excellence Category - in 2024 and 2020 respectively, receiving a Research Australia Digital Health Technology – Highly Commended Award, becoming an Honour of Australia recipient as well as a Fellow of the AAHMS in 2023 and being honoured with a Telstra Health - Brilliant Woman in Digital Health Award in 2022.

Speaker bio

Invited speakers

Dr Kimberly Homan

Dr Kimberly Homan

Dr Kimberly Homan, Ph.D., Senior Director and Distinguished Scientist, Complex in vitro Systems Lab, Translational Safety, Genentech, Inc

Speaker bio

A/Prof George Leung

A/Prof George Leung

A/Prof George Leung's research focuses on herbal medicine, especially medicinal mushrooms, on ageing-related problems such as cardiovascular disorders, neurodegenerative diseases and cancer.

Speaker bio

A/Prof Wing Hin Lee

A/Prof Wing Hin Lee

A/Prof Lee's research focuses on the engineering of personalised inhalable nanoparticles for lung cancer therapy.

Speaker bio

A/Prof Sharon Leung

A/Prof Sharon Leung

A/Prof Leung’s research focuses on the development of advanced drug delivery systems for novel biological antibacterials, including phage and phage-encoded proteins, to combat difficult-to-treat bacterial infections.

Speaker bio

Prof Hsin-I Chang

Prof Hsin-I Chang

Prof Chang's research focuses on polymer modification and application in the medical fields, liposome-based drug delivery systems for skin and bone treatment, and mechanobiology of intervertebral disc cells.

Speaker bio

A/Prof Defang Ouyang

A/Prof Defang Ouyang

A/Prof Defang Ouyang's research centers on computational pharmaceutics, combining artificial intelligence and multi-scale modeling to enhance drug delivery and pharmaceutical formulations.

Speaker bio

A/Prof Lana McClements

A/Prof Lana McClements

A/Prof Lana McClements is a Heart Foundation Future Leader Fellow and an Associate Professor at the Faculty of Science, University of Technology Sydney. She is a world-leading researcher in cardiovascular disease specific to women and has pioneered new diagnostic and treatment platforms, and 3D tissue engineering models towards improving women's health.

Speaker bio

A/Prof Sui Yung Chan

A/Prof Sui Yung Chan

A/Prof Sui Yung Chan is a pharmacist based in Singapore and an Honorary Fellow at the Pharmacy Department, National University of Singapore. With a background in formulation science and pharmacy practice, she co-founded a startup to compound medicated transmucosal films as a painless, safe, and discreet alternative drug delivery system.

Speaker bio

Prof Catherine Tuleu

Prof Catherine Tuleu

Prof Catherine Tuleu is Professor of Paediatric Pharmaceutics at the University College London School of Pharmacy, UK. Her translational research (h-index 40) focuses on developing innovative age-appropriate medicines for babies and children, pioneering sensory pharmaceutics towards better medicine acceptability. Prof Tuleu is the founder and chairperson of the European Paediatric Formulation Initiative (EuPFI), advancing drug product research and development for children.

Speaker bio

Prof Asha Bowen

Prof Asha Bowne

Prof Asha Bowen is a senior Clinician-Scientist in Paediatric Infectious Diseases, working across Perth Children's Hospital and The Kids Research Institute. She is the lead investigator of SToP Trial and global Paediatric lead of the SNAP Trial. Her research focuses on translation of results into clinical practice ranging from bush to bench to bedside and beyond.

Speaker bio

Prof Ben Boyd

Prof Ben Boyd

Prof Ben Boyd is an ARC Industry Laureate Research Fellow and Professor of Drug Delivery Sciences at Monash Institute of Pharmaceutical Sciences in Melbourne, Australia. His research is focussed at the intersection of colloid and interface science with drug delivery sciences, with strong interest in the behaviour of lipid and other colloidal materials in physiological environments and developing methods to study these systems. He has had an interest in the development of novel paediatric formulations for both oral and long-acting parenteral applications.

Speaker bio

Prof Yuan Ping

Prof Yuan Ping

Prof Yuan Ping is a tenured professor and principal investigator at the College of Pharmaceutical Sciences at Zhejiang University, China. His current research mainly focuses on biomacromolecular drug delivery for cancer immunotherapy, inflammatory diseases and gene therapy.

Speaker bio

Knowledge partners

RR MedScience

Industrial Partner

RR MedScience

RR MedSciences is a Sydney-based, clinical stage pharmaceutical company progressing therapeutic candidates for the treatment of pain and inflammatory conditions.

Speaker bio

Taron Solutions

Industrial Partner

Taron Solutions

Taron Solutions is a rising global partnering and drug development accelerator specializing in biologic therapeutics. Over the years, we have successfully helped different products by leveraging our proprietary technology platforms as well as our team's combined 150+ years of international biotech experience in research, formulation, and process development to expedite regulatory approval pathway.

Speaker bio

Craft Health

Industrial Partner

Craft Health

Craft Health is a Singapore-based healthcare and technology company providing automated platform solutions for personalised medicine and supplements. We provide a cutting-edge, innovative, and user-friendly platform that automates the production of personalized medicines, transforming healthcare and improving patient outcomes globally.

Established in 2019 by a team of pharmacists, our platform integrates patented hardware (no heat and UV), software, and standard premix materials. These solutions have been widely adopted across pharmacies, universities, and hospitals for research and development, just-in-time production of high-mix low-volume products, and educational programs.

Speaker bio

Conference themes

Nanomedicine, genomic and personalised medicine
  • Advances in genomics, gene editing, and precision medicine.
  • Ethical/legal considerations and regulatory challenges.
  • Nuclear science in pharmaceutical and medical sciences
Non-animal innovation and alternative testing methods
  • Advancements in in vitro models, organoids, and computational simulations.
  • 3Rs and cruelty-free research and development.
Extracellular vesicles, lipid nanoparticles, viral vectors and advanced drug delivery systems
    • Nanotechnology applications in drug formulation and targeted delivery.
    • Extracellular vesicles as drug delivery vectors and adjuvants.
    • Safety, efficacy, and scalability.
Antimicrobial Resistance (AMR) – global innovations and strategies to overcome AMR: a call to action!
    • Next-generation antimicrobials.
    • Alternative therapies such as bacteriophage-based treatments, CRISPR-Cas antimicrobials, and microbiome-derived agents
    • One health approaches to AMR
    • Regulatory policies and stewardship programs.
3D Printing technology and personalised medicines 
    • Innovations in 3D printing for the pharmaceutical industry.
    • Regulatory considerations in 3D printed pharmaceuticals.
    • Clinical applications and case studies of 3D printed drugs.
AI-driven pharmacy solutions
    • AI for drug discovery, patient care, and supply chain optimization.
    • Ethical implications and data privacy.
Self-driving pharmaceutical laboratories
  • Autonomous labs for sample processing, quality control, and inventory management.
  • Safety protocols and cost-effectiveness.
Industry-pharmacy partnerships for innovation
  • Collaboration between pharmaceutical companies and research institutions.
  • Success stories and best practices.
Digital medicine and therapies
    • Hospital drug management, patient safety, and clinical pharmacy.
    • Interdisciplinary teamwork.
    • Medicine without Meds – transforming Patient Care with Digital Therapies
Age-appropriate paediatric formulations
  • Inaugural forum for an Asian Paediatric Formulation Initiative
  • Development and evaluation of age-appropriate paediatric formulations 
  • Taste-masking strategies for paediatric formulations
Cannabis-based medicines, psychedelics and alternative medicine integration
  • Evidence-based herbal medicine, traditional practices, and holistic approaches – indigenous medicines.
  • Synergies with pharmaceuticals.
Mechanopharmacology and mechanobiology
  • Mechanopharmacology in drug discovery.
  • Mechanobiology as a biomarker in drug development and testing.

Proudly sponsored by

Important dates

2025

27
Mar
Call for abstracts open
31
Jul
Extended abstract submission deadline
4
Sep
Early bird registration closes
3
Dec
Conference commences

© AFPS 2025 Conference

created by Aptly Web Design